# EXTL1

## Overview
EXTL1 (exostosin like glycosyltransferase 1) is a human gene that encodes a glycosyltransferase enzyme involved in the biosynthesis of heparan sulfate (HS), a critical component of the extracellular matrix. The protein product of EXTL1, categorized as a glycosyltransferase, specifically exhibits α1,4-N-acetylglucosaminyltransferase (GlcNAcT-II) activity, facilitating the elongation of HS chains by transferring N-acetylglucosamine to oligosaccharides in the Golgi apparatus (Kim2001Human). This enzymatic function is essential for the proper modification of proteoglycans, which are vital for cellular processes such as signaling, adhesion, and growth factor regulation (Kim2001Human). Although EXTL1 is not directly implicated in hereditary multiple exostoses, a condition linked to other EXT family members, its role in HS biosynthesis suggests potential involvement in tumor suppression and cancer progression (Kim2001Human; Duncan2001The). The gene is located on chromosome 1p36.1, a region associated with tumor suppression, further underscoring its potential significance in oncological research (Kim2001Human).

## Function
EXTL1 (exostosin like glycosyltransferase 1) encodes an enzyme with α1,4-N-acetylglucosaminyltransferase (GlcNAcT-II) activity, which plays a crucial role in the biosynthesis of heparan sulfate (HS) in healthy human cells. This enzyme is responsible for transferring N-acetylglucosamine (GlcNAc) to N-acetylheparosan oligosaccharides, forming an α1,4-linkage to the nonreducing terminal glucuronic acid (GlcA) of the oligosaccharides. This activity is essential for the elongation of HS chains, contributing to the formation of the repeating disaccharide region of HS (Kim2001Human).

EXTL1 is active in the Golgi apparatus, where it participates in the modification of proteoglycans, which are critical for various cellular functions, including cell signaling, cell adhesion, and the regulation of growth factors (Kim2001Human). Although EXTL1 is not involved in the initiation of HS chains, it is crucial for their polymerization, distinguishing its role from other members of the EXT gene family, such as EXTL3, which is involved in both initiation and elongation (Kim2001Human). The enzyme's activity is not associated with glucuronyltransferase activity, highlighting its specific function in HS biosynthesis (Kim2001Human).

## Clinical Significance
The EXTL1 gene, part of the human tumor suppressor ext gene family, is implicated in the biosynthesis of heparan sulfate (HS) and heparin (Hep), which are crucial for various biological processes. Alterations in EXTL1 expression or function can have significant clinical implications. Although EXTL1 is not directly linked to hereditary multiple exostoses (HME), a disorder associated with other EXT family members, its role in HS biosynthesis suggests potential involvement in tumor suppression and cancer progression (Kim2001Human; Duncan2001The).

EXTL1's expression is tissue-specific, detected in skeletal muscles, brain, heart, and liver in mice, but not in human Northern blots, indicating spatiotemporally regulated functions (Kim2001Human). This specificity suggests that disruptions in EXTL1 expression could contribute to tissue-specific pathologies, although direct clinical correlations remain to be fully elucidated.

The gene is located at chromosomal locus 1p36.1, a region associated with tumor suppression, as deletions in this area have been observed in various tumors, indicating that EXTL1 may play a role in tumorigenesis (Kim2001Human). However, the precise clinical significance of EXTL1 interactions, particularly its GlcNAcT-II activity, is not yet fully understood (Kim2001Human).


## References


[1. (Kim2001Human) Byung-Taek Kim, Hiroshi Kitagawa, Jun-ichi Tamura, Toshiyuki Saito, Marion Kusche-Gullberg, Ulf Lindahl, and Kazuyuki Sugahara. Human tumor suppressor ext gene family members extl1 and extl3 encode α1,4- n -acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis. Proceedings of the National Academy of Sciences, 98(13):7176–7181, June 2001. URL: http://dx.doi.org/10.1073/pnas.131188498, doi:10.1073/pnas.131188498. This article has 136 citations.](https://doi.org/10.1073/pnas.131188498)

[2. (Duncan2001The) Gillian Duncan, Craig McCormick, and Frank Tufaro. The link between heparan sulfate and hereditary bone disease: finding a function for the ext family of putative tumor suppressor proteins. Journal of Clinical Investigation, 108(4):511–516, August 2001. URL: http://dx.doi.org/10.1172/jci200113737, doi:10.1172/jci200113737. This article has 8 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci200113737)